Drug Development Industry Articles & Analysis
12 news found
The screening of substrates, inhibitors, and other ligands is a pivotal facet of enzyme research, enabling scientists to pinpoint compounds best suited for a variety of applications, from drug development to industrial processes. A profound understanding of enzyme-molecule interactions can pave the way for groundbreaking therapies, improved ...
Recently, the company introduced a series of state-of-the-art services in Drug Design and Computer-Aided Drug Design (CADD) with the aim of providing efficient and reliable solutions for the pharmaceutical industry's drug development endeavors. ...
The company's risk-sharing partnership offerings allow organizations to co-develop new drugs using BIOiSIM™ and, hence, predict translation from bench to bedside, reduce R&D costs, lower the risk of selecting new drug candidates, and condense the development time for promising drugs. ...
The company is also co-developing new drugs with Mayo Clinic in key disease areas, including oncology, hematology, bone/joint disorders, and neurological diseases. ...
The potential applications are subject to the requisite clinical and regulatory commercialization processes. The global psychedelic drugs market is expected to gain significant market growth in the forecast period from 2022 to 2029. ...
VeriSIM offers unprecedented value for the drug development industry by reducing the number of drug compounds likely to treat or cure specific illnesses and diseases. ...
1 Establishment of new drug pipeline with bilirubin platform technology Securing global competitiveness by increasing corporate value “I want to give hope to those who are living a difficult life with an incurable disease” [IB Tomato Lim Seong-ji] “The new drug development industry is a specialized area that is ...
[IB Tomato Reporter Lim Seong-ji] “The new drug development industry is a specialized area that is difficult for general investors and shareholders to understand, and it is difficult to deliver accurate information even when publicly available. The bad examples of some companies that have been inflated even with content are hindering the ...
At Celdara Medical, I help build the foundation for the development of early-stage innovation into life-changing treatment options. ...
Ariana, a leading eXplainable Artificial Intelligence (AI) drug development company, is delighted to announce the appointment of Dr. ...
The CMO Leadership Awards, based on the annual Contract Manufacturing Quality Benchmarking survey conducted by Industry Standard Research (ISR), assessed more than 70 contract manufacturers on 23 performance metrics. ...
Louise Proulx is a science executive with years of experience in the drug development industry. Most recently, she has served as the Co-Founder of Therillia Development Company and a Venture Partner with Sanderling Ventures. ...